Searched for
WOCKHARDT PLANT
Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
Wockhardt shuts US manufacturing plantThe company expects the US plant shutdown and transfer of products from inhouse to third-party contract manufacturers to help save $12 mill...
USFDA issues warning letter to Wockhardt's Ankleshwar plantUSFDA has already banned import of products from the facility into the US market since August 5, 2016.
- Neutral Wockhardt Ltd., target Rs 1015.0 : Macquarie Capital Securities
Macquarie says expects stock to trade at discount to fair value of Rs 1,320 in the medium term as regulatory uncertainty prevails
Wockhardt's Chikalthana plant gets GMP certificate from UKMHRAIn a major relief to drug firm Wockhardt, its Chikalthana plant at Aurangabad in Maharashtra has received a good manufacturing practice cer...
UK MHRA completes inspection of Wockhardt's Chikalthana plantWockhardt said the UK health regulator has completed inspection of its plant at Chikalthana without issuing any critical observations on th...
USFDA finds procedural lapses at Wockhardt's US facilityThe US Food and Drug Administration has found as many as 12 procedural lapses in drug maker Wockhardt's US facility in Illinois.
Wockhardt recalls over 109,000 bottles of hypertension drug in USWockhardt Ltd is recalling 109,744 bottles of a high blood pressure drug in the US after it failed a dissolution test, the US Food and Drug...
Why multibagger Wockhardt is on analysts' 'sell' radar nowFundamental troubles or the regulatory problems are not going to go away in a hurry for Wockhardt and it has become more of a trading stock...
Wockhardt plunges 14% as USFDA issues import alert on Chikalthana PlantThe Chikalthana facility received ‘483’ observations after the USFDA raised several concerns. This is the second plant in India to get impo...
Wockhardt may face £1 million hit due to Kadaiya unit lapsesWockhardt today said it will take a revenue hit of nearly one million pounds due to import restrictions imposed by the UK health regulator ...
Another Wockhardt plant under MHRA scannerThis is the drug maker's second plant whose GMP certificate has been taken away by MHRA and the third to face regulatory heat this year.
- Wockhardt continues to slide as street loses faith
On July 18, the US FDA said in a warning letter that the company “repeatedly delayed, denied, limited an inspection or refused to permit th...
Wockhardt skids 20% on US warning over manufacturing practicesShares in Mumbai-based drug maker Wockhardt plunged 20% on Wednesday after details emerged of a warning by the US Food and Drug Administrat...
Wockhardt gets warning letter from USFDA over Waluj plantWockhardt said it has received a warning letter from US health regulator over its facility at Waluj in Maharashtra not meeting manufacturin...
UK regulator MHRA recalls 16 drugs made at Wockhardt's Waluj plantMHRA today said it has issued a precautionary recall for sixteen medicines made by Wockhardt at its Waluj unit due to manufacturing shortco...
Wockhardt allays investor fears on US 'import ban'USFDA had imposed a ban on imports from Wockhardt's Aurangabad factory in Maharashtra, citing quality concerns of drugs.
- Wockhardt gets USFDA approval to market generic Protonix
The company will manufacture the generic tablets at its US Food and Drug Administration's certified plant at Waluj, Maharashtra.
- Wockhardt gets USFDA tentative nod for generic rhinitis drug
Pharmaceutical and biotechnology firm Wockhardt today said it has received tentative approval from USFDA to sell generic version of Sanofi ...
- Fire damages Wockhardt's unit at Ankleshwar
A fire at pharmaceutical major Wockhardt’s Rs 300-crore Ankleshwar facility damaged one of its six manufacturing plants.